Related Experiment Videos
Antigen analogs/MHC complexes as specific T cell receptor antagonists
A Sette1, J Alexander, J Ruppert
1Cytel, San Diego, California 92121.
Annual Review of Immunology
|January 1, 1994
Summary
Antigen analogs inhibit T cell activation by acting as T cell receptor (TCR) antagonists. This discovery offers potential for treating allergies and autoimmune diseases.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Antigen analogs can inhibit T cell activation.
- This led to the concept of T cell receptor (TCR) antagonism.
Purpose of the Study:
- To explore the mechanism of TCR antagonism.
- To investigate the potential of TCR antagonists for immunointervention.
- To utilize TCR antagonist peptides as tools for studying thymic education.
Main Methods:
- Investigating TCR antagonism at the molecular level.
- Analyzing the role of affinity thresholds in T cell activation.
- Examining the impact on membrane-related events like receptor clustering.
Main Results:
- TCR antagonism occurs below a critical affinity threshold.
- Antagonists may interfere with pre-signaling events such as receptor clustering.
- Feasibility of antigen-specific immunointervention is under investigation.
Conclusions:
- TCR antagonism presents a novel mechanism for controlling T cell responses.
- This phenomenon holds promise for developing targeted therapies for immune-related disorders.
- TCR antagonist peptides are valuable for understanding T cell-MHC interactions.